FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W23303650> ?p ?o ?g. }

• W23303650 endingPage "116" @default.
• W23303650 startingPage "107" @default.
• W23303650 abstract "During the last two decades a significant number of investigations has established the fact that α-Melanocyte-stimulating hormone (α-MSH) is a potent anti-inflammatory mediator. The anti-inflammatory effects of α-MSH can be elicited via melanocortin receptors (MC-Rs) broadly expressed in a number of tissues ranging from the central nervous system to cells of the immune system and on resident somatic cells of peripheral tissues. α-MSH affects various pathways regulating inflammatory responses such as NF-κB activation, expression of adhesion molecules, inflammatory cytokines, chemokine receptors, T-cell proliferation and activity and inflammatory cell migration. In vivo α-MSH has been shown to be anti-inflammatory as well in animal models of fever, irritant and allergic contact dermatitis, cutaneous vasculitis, fibrosis, in ocular, gastrointestinal, brain and allergic airway inflammation and arthritis. A broad range of effects of α-MSH exerted beyond the field of inflammation, its pigmentory capacity being only the most visible aspect, has been one of the major impediments limiting the use of α-MSH in human inflammatory disorders. Interestingly KPV, C-terminal tripeptide of α-MSH, which lacks the entire sequence motif required for binding to any of the known MC-Rs, retains almost all of the anti-inflammatory capacity of the full hormone, but in its activities display a lack of any pigmentory action. While the exact signaling mechanism utilized by KPV and related peptides currently is unknown it has been demonstrated already that significant similarities between anti-inflammatory signaling of α-MSH and those short peptides exist. These α-MSH related tripeptides thus may be useful alternatives for anti-inflammatory peptide therapy. KdPT, a derivative of KPV corresponding to IL-1β193–195, currently is emerging as another tripeptide with potent anti-inflammatory effects. A more limited spectrum of biologic activities, potentially advantageous physicochemical, pharmacokinetic and pharmacodynamic properties as well as the expectation of low costs for pharmaceutical production make these agents interesting candidates for the treatment of immune-mediated inflammatory skin and bowel diseases, allergic asthma and arthritis." @default.
• W23303650 created "2016-06-24" @default.
• W23303650 creator A5038698440 @default.
• W23303650 creator A5044496150 @default.
• W23303650 creator A5052160547 @default.
• W23303650 creator A5063249836 @default.
• W23303650 creator A5079571425 @default.
• W23303650 date "2010-01-01" @default.
• W23303650 modified "2023-10-16" @default.
• W23303650 title "Terminal Signal: Anti-Inflammatory Effects of α-Melanocyte-Stimulating Hormone Related Peptides Beyond the Pharmacophore" @default.
• W23303650 cites W1499478544 @default.
• W23303650 cites W1562925757 @default.
• W23303650 cites W1593022712 @default.
• W23303650 cites W1624229824 @default.
• W23303650 cites W1827384741 @default.
• W23303650 cites W1889056855 @default.
• W23303650 cites W1969395460 @default.
• W23303650 cites W1970951686 @default.
• W23303650 cites W1971448527 @default.
• W23303650 cites W1971953383 @default.
• W23303650 cites W1973223056 @default.
• W23303650 cites W1976261739 @default.
• W23303650 cites W1977478876 @default.
• W23303650 cites W1979420492 @default.
• W23303650 cites W1984013161 @default.
• W23303650 cites W1985263819 @default.
• W23303650 cites W1986171482 @default.
• W23303650 cites W1998341792 @default.
• W23303650 cites W2007272957 @default.
• W23303650 cites W2013073212 @default.
• W23303650 cites W2014966737 @default.
• W23303650 cites W2017458853 @default.
• W23303650 cites W2018317606 @default.
• W23303650 cites W2030574509 @default.
• W23303650 cites W2031918462 @default.
• W23303650 cites W2035034857 @default.
• W23303650 cites W2035998510 @default.
• W23303650 cites W2037966248 @default.
• W23303650 cites W2040902673 @default.
• W23303650 cites W2041928527 @default.
• W23303650 cites W2042694509 @default.
• W23303650 cites W2049674755 @default.
• W23303650 cites W2051828350 @default.
• W23303650 cites W2055867580 @default.
• W23303650 cites W2059535343 @default.
• W23303650 cites W2061364771 @default.
• W23303650 cites W2063743408 @default.
• W23303650 cites W2064480241 @default.
• W23303650 cites W2066833257 @default.
• W23303650 cites W2067541478 @default.
• W23303650 cites W2069423064 @default.
• W23303650 cites W2073686733 @default.
• W23303650 cites W2077744618 @default.
• W23303650 cites W2081504735 @default.
• W23303650 cites W2083471149 @default.
• W23303650 cites W2087214422 @default.
• W23303650 cites W2094828639 @default.
• W23303650 cites W2095752238 @default.
• W23303650 cites W2121252248 @default.
• W23303650 cites W2140846345 @default.
• W23303650 cites W2141488753 @default.
• W23303650 cites W2141755052 @default.
• W23303650 cites W2142000133 @default.
• W23303650 cites W2158603587 @default.
• W23303650 cites W2164587545 @default.
• W23303650 cites W2435170652 @default.
• W23303650 cites W2623145239 @default.
• W23303650 cites W4294359977 @default.
• W23303650 cites W4312659511 @default.
• W23303650 doi "https://doi.org/10.1007/978-1-4419-6354-3_8" @default.
• W23303650 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21222263" @default.
• W23303650 hasPublicationYear "2010" @default.
• W23303650 type Work @default.
• W23303650 sameAs 23303650 @default.
• W23303650 citedByCount "26" @default.
• W23303650 countsByYear W233036502012 @default.
• W23303650 countsByYear W233036502013 @default.
• W23303650 countsByYear W233036502014 @default.
• W23303650 countsByYear W233036502015 @default.
• W23303650 countsByYear W233036502016 @default.
• W23303650 countsByYear W233036502017 @default.
• W23303650 countsByYear W233036502020 @default.
• W23303650 countsByYear W233036502021 @default.
• W23303650 countsByYear W233036502022 @default.
• W23303650 crossrefType "book-chapter" @default.
• W23303650 hasAuthorship W23303650A5038698440 @default.
• W23303650 hasAuthorship W23303650A5044496150 @default.
• W23303650 hasAuthorship W23303650A5052160547 @default.
• W23303650 hasAuthorship W23303650A5063249836 @default.
• W23303650 hasAuthorship W23303650A5079571425 @default.
• W23303650 hasConcept C13373296 @default.
• W23303650 hasConcept C170493617 @default.
• W23303650 hasConcept C185592680 @default.
• W23303650 hasConcept C203014093 @default.
• W23303650 hasConcept C2776914184 @default.
• W23303650 hasConcept C2779993316 @default.
• W23303650 hasConcept C2780989459 @default.
• W23303650 hasConcept C55493867 @default.

• next